Henry Lawrence Dorkin, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cystic Fibrosis | 23 | 2020 | 1285 | 0.700 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 9 | 2011 | 450 | 0.340 |
Why?
|
| Neonatal Screening | 7 | 2010 | 597 | 0.290 |
Why?
|
| Pulmonary Medicine | 2 | 2019 | 221 | 0.180 |
Why?
|
| Airway Resistance | 6 | 1996 | 406 | 0.160 |
Why?
|
| Deoxyribonuclease I | 2 | 1994 | 224 | 0.140 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2015 | 167 | 0.120 |
Why?
|
| Expectorants | 1 | 1994 | 22 | 0.120 |
Why?
|
| Specialization | 1 | 2019 | 778 | 0.110 |
Why?
|
| Genetic Counseling | 3 | 2005 | 627 | 0.100 |
Why?
|
| Respiratory Mechanics | 3 | 1996 | 699 | 0.090 |
Why?
|
| Trypsinogen | 3 | 2010 | 84 | 0.090 |
Why?
|
| Benzodioxoles | 1 | 2011 | 75 | 0.090 |
Why?
|
| Respiratory System Abnormalities | 1 | 2011 | 67 | 0.090 |
Why?
|
| DNA Mutational Analysis | 6 | 2011 | 4111 | 0.090 |
Why?
|
| Lung Transplantation | 1 | 2020 | 1310 | 0.090 |
Why?
|
| Sweat | 2 | 2010 | 56 | 0.080 |
Why?
|
| Chlorides | 4 | 2010 | 665 | 0.080 |
Why?
|
| Referral and Consultation | 3 | 2020 | 3600 | 0.080 |
Why?
|
| Lung Diseases | 2 | 2011 | 1909 | 0.080 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 1578 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2020 | 4016 | 0.070 |
Why?
|
| Aminopyridines | 1 | 2011 | 573 | 0.070 |
Why?
|
| Pediatrics | 2 | 2019 | 3589 | 0.070 |
Why?
|
| Adenoviridae | 2 | 2001 | 1085 | 0.070 |
Why?
|
| Pseudomonas Infections | 2 | 2006 | 622 | 0.070 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 1987 | 189 | 0.070 |
Why?
|
| Vascular Malformations | 1 | 2011 | 468 | 0.060 |
Why?
|
| Iontophoresis | 1 | 2005 | 74 | 0.060 |
Why?
|
| Bacillus | 1 | 2005 | 78 | 0.060 |
Why?
|
| Mycobacterium smegmatis | 1 | 2005 | 126 | 0.060 |
Why?
|
| Administration, Inhalation | 4 | 2015 | 1157 | 0.060 |
Why?
|
| Plethysmography, Whole Body | 1 | 1983 | 25 | 0.060 |
Why?
|
| Oscillometry | 2 | 1983 | 150 | 0.060 |
Why?
|
| Program Development | 2 | 2010 | 1297 | 0.050 |
Why?
|
| Pulmonary Ventilation | 2 | 1982 | 372 | 0.050 |
Why?
|
| Dependovirus | 1 | 2007 | 718 | 0.050 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1983 | 233 | 0.050 |
Why?
|
| Respiration | 1 | 1988 | 1657 | 0.050 |
Why?
|
| Respiratory Mucosa | 2 | 2001 | 439 | 0.050 |
Why?
|
| Lung Compliance | 3 | 1996 | 200 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2005 | 1139 | 0.040 |
Why?
|
| Forced Expiratory Volume | 3 | 2020 | 1814 | 0.040 |
Why?
|
| Acoustics | 1 | 1980 | 242 | 0.040 |
Why?
|
| Infant, Newborn | 10 | 2011 | 26198 | 0.040 |
Why?
|
| Yersinia Infections | 1 | 1978 | 9 | 0.040 |
Why?
|
| DNA | 2 | 2011 | 7213 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2005 | 2192 | 0.040 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 1999 | 168 | 0.040 |
Why?
|
| Leukocyte Elastase | 2 | 2015 | 114 | 0.040 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1983 | 589 | 0.040 |
Why?
|
| Genetic Testing | 4 | 2010 | 3537 | 0.040 |
Why?
|
| Pharynx | 1 | 1980 | 432 | 0.040 |
Why?
|
| New England | 1 | 2020 | 1054 | 0.030 |
Why?
|
| Genetic Vectors | 3 | 2001 | 3396 | 0.030 |
Why?
|
| Workload | 2 | 2019 | 844 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2001 | 1206 | 0.030 |
Why?
|
| Deoxyribonucleases | 1 | 1997 | 211 | 0.030 |
Why?
|
| Massachusetts | 5 | 2010 | 8830 | 0.030 |
Why?
|
| Algorithms | 4 | 2010 | 14032 | 0.030 |
Why?
|
| Transfection | 2 | 2001 | 5774 | 0.030 |
Why?
|
| Parents | 2 | 2005 | 3563 | 0.030 |
Why?
|
| Models, Biological | 2 | 1988 | 9469 | 0.030 |
Why?
|
| Program Evaluation | 3 | 2010 | 2495 | 0.030 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2015 | 175 | 0.030 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 1999 | 366 | 0.030 |
Why?
|
| Trachea | 1 | 1980 | 1089 | 0.030 |
Why?
|
| Elastin | 1 | 1995 | 298 | 0.030 |
Why?
|
| Bile Ducts | 1 | 1995 | 282 | 0.030 |
Why?
|
| Nebulizers and Vaporizers | 1 | 1994 | 139 | 0.030 |
Why?
|
| Computational Biology | 1 | 2005 | 3517 | 0.030 |
Why?
|
| Tobramycin | 1 | 1993 | 65 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2005 | 4217 | 0.030 |
Why?
|
| Sputum | 1 | 2015 | 506 | 0.030 |
Why?
|
| Mutation | 4 | 2011 | 30054 | 0.030 |
Why?
|
| Bronchitis | 1 | 1993 | 196 | 0.030 |
Why?
|
| Double-Blind Method | 4 | 2015 | 12341 | 0.030 |
Why?
|
| Patient Preference | 1 | 2020 | 924 | 0.030 |
Why?
|
| Recombinant Proteins | 3 | 2001 | 6534 | 0.030 |
Why?
|
| Models, Organizational | 2 | 2005 | 546 | 0.020 |
Why?
|
| Sweat Glands | 1 | 2011 | 33 | 0.020 |
Why?
|
| Humans | 37 | 2020 | 761572 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2005 | 3205 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 10766 | 0.020 |
Why?
|
| Communication | 1 | 2005 | 3873 | 0.020 |
Why?
|
| DNA, Recombinant | 2 | 2001 | 455 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 3 | 2001 | 6075 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 1993 | 432 | 0.020 |
Why?
|
| Male | 22 | 2019 | 360842 | 0.020 |
Why?
|
| Female | 22 | 2019 | 392686 | 0.020 |
Why?
|
| Aftercare | 2 | 2005 | 914 | 0.020 |
Why?
|
| Amino Acids | 1 | 1995 | 1718 | 0.020 |
Why?
|
| Adult | 15 | 2015 | 221203 | 0.020 |
Why?
|
| Nitrogen | 1 | 1990 | 348 | 0.020 |
Why?
|
| Follow-Up Studies | 5 | 2015 | 39107 | 0.020 |
Why?
|
| Membrane Proteins | 3 | 1995 | 7858 | 0.020 |
Why?
|
| Aerosols | 3 | 1997 | 635 | 0.020 |
Why?
|
| Time Factors | 6 | 2015 | 39970 | 0.020 |
Why?
|
| Collagen | 1 | 1995 | 2638 | 0.020 |
Why?
|
| Infant | 5 | 2011 | 36192 | 0.020 |
Why?
|
| Immunoassay | 1 | 2010 | 745 | 0.020 |
Why?
|
| Homozygote | 1 | 2011 | 1776 | 0.020 |
Why?
|
| Mathematics | 1 | 1987 | 707 | 0.020 |
Why?
|
| Reference Values | 3 | 2005 | 4920 | 0.020 |
Why?
|
| Pilocarpine | 1 | 2005 | 64 | 0.020 |
Why?
|
| Chromatography, Gas | 1 | 2005 | 151 | 0.020 |
Why?
|
| Histidine | 1 | 2006 | 308 | 0.020 |
Why?
|
| Sensitivity and Specificity | 3 | 2005 | 14666 | 0.020 |
Why?
|
| Bronchoscopy | 2 | 2001 | 909 | 0.020 |
Why?
|
| Muscarinic Agonists | 1 | 2005 | 91 | 0.020 |
Why?
|
| Parental Consent | 1 | 2005 | 63 | 0.020 |
Why?
|
| Decision Making, Organizational | 1 | 2005 | 136 | 0.020 |
Why?
|
| Physician Executives | 1 | 2005 | 134 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 2005 | 573 | 0.010 |
Why?
|
| Adolescent | 10 | 2011 | 88324 | 0.010 |
Why?
|
| Pyrophosphatases | 2 | 1975 | 142 | 0.010 |
Why?
|
| Lung | 4 | 2011 | 10002 | 0.010 |
Why?
|
| Methods | 2 | 1982 | 1067 | 0.010 |
Why?
|
| Sepsis | 1 | 1978 | 2585 | 0.010 |
Why?
|
| Decision Trees | 1 | 2005 | 504 | 0.010 |
Why?
|
| Respiratory Paralysis | 1 | 1983 | 32 | 0.010 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2011 | 1755 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2005 | 957 | 0.010 |
Why?
|
| Placebos | 1 | 2007 | 1667 | 0.010 |
Why?
|
| Arginine | 1 | 2006 | 934 | 0.010 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 1983 | 108 | 0.010 |
Why?
|
| Child | 7 | 2011 | 80156 | 0.010 |
Why?
|
| Dogs | 1 | 1987 | 3839 | 0.010 |
Why?
|
| Genotype | 3 | 2006 | 12990 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1987 | 1736 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1999 | 9177 | 0.010 |
Why?
|
| Instillation, Drug | 1 | 2001 | 32 | 0.010 |
Why?
|
| Primary Health Care | 2 | 2010 | 4686 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2005 | 829 | 0.010 |
Why?
|
| Point Mutation | 1 | 2006 | 1595 | 0.010 |
Why?
|
| Physicians | 1 | 2019 | 4591 | 0.010 |
Why?
|
| Electrolytes | 1 | 2001 | 274 | 0.010 |
Why?
|
| Sweating | 1 | 2001 | 155 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 2005 | 1186 | 0.010 |
Why?
|
| Hypopharynx | 1 | 1980 | 53 | 0.010 |
Why?
|
| Quality Indicators, Health Care | 1 | 2010 | 1792 | 0.010 |
Why?
|
| Middle Aged | 7 | 2019 | 220920 | 0.010 |
Why?
|
| Oropharynx | 1 | 1980 | 138 | 0.010 |
Why?
|
| Age of Onset | 1 | 2006 | 3306 | 0.010 |
Why?
|
| Drug Industry | 1 | 1985 | 788 | 0.010 |
Why?
|
| Spirometry | 1 | 1982 | 929 | 0.010 |
Why?
|
| Glottis | 1 | 1980 | 214 | 0.010 |
Why?
|
| Feasibility Studies | 2 | 2004 | 5247 | 0.010 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2006 | 1277 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2011 | 20571 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2001 | 903 | 0.010 |
Why?
|
| Epithelium | 2 | 1995 | 1603 | 0.010 |
Why?
|
| Models, Anatomic | 1 | 1982 | 683 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1994 | 8002 | 0.010 |
Why?
|
| Pulmonary Emphysema | 1 | 1983 | 684 | 0.010 |
Why?
|
| Mouth | 1 | 1980 | 381 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2006 | 2571 | 0.010 |
Why?
|
| Immunoglobulin Isotypes | 1 | 1997 | 158 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2015 | 64684 | 0.010 |
Why?
|
| Bacteriological Techniques | 1 | 1978 | 275 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2005 | 2025 | 0.010 |
Why?
|
| Bronchial Hyperreactivity | 1 | 1997 | 302 | 0.010 |
Why?
|
| Isodesmosine | 1 | 1995 | 6 | 0.010 |
Why?
|
| Desmosine | 1 | 1995 | 19 | 0.010 |
Why?
|
| Dysautonomia, Familial | 1 | 1976 | 94 | 0.010 |
Why?
|
| Social Support | 1 | 2005 | 2171 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 1983 | 1333 | 0.010 |
Why?
|
| Linear Models | 1 | 2005 | 5872 | 0.010 |
Why?
|
| Pancreatic Elastase | 1 | 1995 | 127 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2001 | 2510 | 0.010 |
Why?
|
| Heterozygote | 1 | 2001 | 2787 | 0.010 |
Why?
|
| Receptors, Complement | 1 | 1995 | 253 | 0.010 |
Why?
|
| Vital Capacity | 1 | 1997 | 971 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1995 | 555 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 15266 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 1976 | 564 | 0.010 |
Why?
|
| Patient Selection | 1 | 2005 | 4244 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1995 | 1085 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2000 | 2426 | 0.010 |
Why?
|
| Cheek | 1 | 1993 | 65 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1995 | 755 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2011 | 42230 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1997 | 1395 | 0.010 |
Why?
|
| Safety | 1 | 1997 | 1150 | 0.010 |
Why?
|
| United States | 2 | 2019 | 72335 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 1996 | 1682 | 0.010 |
Why?
|
| Oxygen | 1 | 1983 | 4227 | 0.010 |
Why?
|
| Decision Making | 1 | 2005 | 3929 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2005 | 3889 | 0.010 |
Why?
|
| Forecasting | 1 | 2000 | 2928 | 0.010 |
Why?
|
| Asthma | 1 | 1990 | 6234 | 0.010 |
Why?
|
| Calcimycin | 1 | 1990 | 213 | 0.010 |
Why?
|
| Risk Factors | 3 | 2005 | 74213 | 0.010 |
Why?
|
| Theophylline | 1 | 1990 | 131 | 0.010 |
Why?
|
| Base Sequence | 2 | 1993 | 12441 | 0.010 |
Why?
|
| Bradykinin | 1 | 1990 | 208 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 416 | 0.010 |
Why?
|
| Calgranulin A | 1 | 1990 | 80 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1990 | 291 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1990 | 257 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1990 | 817 | 0.010 |
Why?
|
| Pregnancy | 1 | 2011 | 29876 | 0.010 |
Why?
|
| Chloride Channels | 1 | 1990 | 221 | 0.010 |
Why?
|
| Dyspnea | 1 | 1997 | 1347 | 0.010 |
Why?
|
| Keratins | 1 | 1990 | 498 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1997 | 4853 | 0.010 |
Why?
|
| Infant, Premature | 1 | 1999 | 2107 | 0.010 |
Why?
|
| Albuterol | 1 | 1990 | 213 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2010 | 80646 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1993 | 1574 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1993 | 17635 | 0.010 |
Why?
|
| Cell Line | 2 | 1995 | 15601 | 0.000 |
Why?
|
| Education, Medical | 1 | 2000 | 1725 | 0.000 |
Why?
|
| Age Factors | 1 | 2005 | 18398 | 0.000 |
Why?
|
| Drug Hypersensitivity | 1 | 1997 | 917 | 0.000 |
Why?
|
| Pilot Projects | 1 | 2001 | 8633 | 0.000 |
Why?
|
| Specimen Handling | 1 | 1993 | 702 | 0.000 |
Why?
|
| Retroviridae | 1 | 1990 | 850 | 0.000 |
Why?
|
| Nasal Mucosa | 1 | 1990 | 416 | 0.000 |
Why?
|
| Membrane Potentials | 1 | 1990 | 1090 | 0.000 |
Why?
|
| Liver | 1 | 1983 | 7529 | 0.000 |
Why?
|
| Chi-Square Distribution | 1 | 1993 | 3416 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2011 | 13382 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2011 | 54426 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 2001 | 12794 | 0.000 |
Why?
|
| Bronchi | 1 | 1990 | 845 | 0.000 |
Why?
|
| Ion Channels | 1 | 1990 | 1040 | 0.000 |
Why?
|
| Monitoring, Physiologic | 1 | 1993 | 1779 | 0.000 |
Why?
|
| Blood Proteins | 1 | 1990 | 1173 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1997 | 4544 | 0.000 |
Why?
|
| Centrifugation, Density Gradient | 2 | 1975 | 299 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1993 | 6228 | 0.000 |
Why?
|
| Young Adult | 1 | 2011 | 59255 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1974 | 2413 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 36429 | 0.000 |
Why?
|
| Financing, Organized | 1 | 1985 | 204 | 0.000 |
Why?
|
| Quality of Life | 2 | 1997 | 13367 | 0.000 |
Why?
|
| Economic Competition | 1 | 1985 | 219 | 0.000 |
Why?
|
| Computer Simulation | 1 | 1996 | 6241 | 0.000 |
Why?
|
| Health Services Accessibility | 1 | 2000 | 5440 | 0.000 |
Why?
|
| Neutrophils | 1 | 1995 | 3767 | 0.000 |
Why?
|
| Inflammation | 1 | 2001 | 10773 | 0.000 |
Why?
|
| Animals | 3 | 1995 | 168467 | 0.000 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1990 | 2827 | 0.000 |
Why?
|
| Epithelial Cells | 1 | 1990 | 3677 | 0.000 |
Why?
|
| Aged | 3 | 2000 | 169310 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 1995 | 22176 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1976 | 861 | 0.000 |
Why?
|
| Binding, Competitive | 1 | 1976 | 1141 | 0.000 |
Why?
|
| London | 1 | 1975 | 234 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1990 | 18965 | 0.000 |
Why?
|
| Drug Stability | 1 | 1975 | 291 | 0.000 |
Why?
|
| Cross Reactions | 1 | 1976 | 817 | 0.000 |
Why?
|
| Electrophoresis, Starch Gel | 1 | 1974 | 19 | 0.000 |
Why?
|
| Freezing | 1 | 1975 | 311 | 0.000 |
Why?
|
| Blood Protein Electrophoresis | 1 | 1974 | 66 | 0.000 |
Why?
|
| Hybridization, Genetic | 1 | 1974 | 103 | 0.000 |
Why?
|
| Biological Assay | 1 | 1976 | 626 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1974 | 645 | 0.000 |
Why?
|
| Phenotype | 1 | 1990 | 16592 | 0.000 |
Why?
|
| Sulfhydryl Compounds | 1 | 1974 | 301 | 0.000 |
Why?
|
| Phosphates | 1 | 1975 | 770 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1974 | 2186 | 0.000 |
Why?
|
| Mice | 2 | 1995 | 81533 | 0.000 |
Why?
|
| Antigens | 1 | 1976 | 1443 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1975 | 2496 | 0.000 |
Why?
|
| Rabbits | 1 | 1976 | 4772 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1974 | 1085 | 0.000 |
Why?
|
| Isoenzymes | 1 | 1974 | 1687 | 0.000 |
Why?
|
| Hemoglobins | 1 | 1975 | 1526 | 0.000 |
Why?
|
| India | 1 | 1975 | 2348 | 0.000 |
Why?
|
| Europe | 1 | 1975 | 3422 | 0.000 |
Why?
|
| Kinetics | 1 | 1975 | 6374 | 0.000 |
Why?
|
| Pedigree | 1 | 1975 | 4542 | 0.000 |
Why?
|
| Peptides | 1 | 1976 | 4358 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1976 | 5112 | 0.000 |
Why?
|